Unlicensed and off-label prescription of respiratory drugs to children

European Respiratory Journal

Volumn 23, Issue 2, 2004, Pages 310-313

  Jong, G W ^a,b   Eland, I A ^b   Sturkenboom, M C J M ^b   van den Anker, J N ^a,d,e   Stricker, B H C ^b,c  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Drug Safety Unit   (Netherlands)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

^e GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Children; Drug use; Epidemiology; Off label; Respiratory; Unlicensed

Indexed keywords

ANTIASTHMATIC AGENT; ANTIHISTAMINIC AGENT; ANTITUSSIVE AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DEPTROPINE; EXPECTORANT AGENT; FLUTICASONE; MUCOLYTIC AGENT; OPIATE; OPIATE DERIVATIVE; PHENOTHIAZINE; PIPERAZINE DERIVATIVE; PROMETHAZINE; SALBUTAMOL; TERBUTALINE; XYLOMETAZOLINE;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DRUG APPROVAL; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG LABELING; DRUG RESEARCH; DRUG SAFETY; FEMALE; GENERAL PRACTITIONER; HUMAN; INFANT; MALE; MEDICAL RECORD; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; REGISTER; RESPIRATORY TRACT INFECTION; RHINITIS; SINUSITIS;

ADOLESCENT; CHEMISTRY, PHARMACEUTICAL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; DRUG ADMINISTRATION ROUTES; DRUG APPROVAL; DRUG COMPOUNDING; DRUG UTILIZATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; PRESCRIPTIONS, DRUG; PRIMARY HEALTH CARE; RESPIRATORY SYSTEM AGENTS; RISK; RISK FACTORS; SWEDEN; TREATMENT OUTCOME;

EID: 1042292624     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00015404     Document Type: Article

References (32)

1. Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999; 80: F142-F144.
2. Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ 1998; 316: 343-345.
3. Turner S, Nunn A, Choonara I. Unlicensed drug use in children in the UK. Paediatr Perinat Drug Ther 1997; 2: 52-55.
4. Turner S, Gill A, Nunn T, Hewitt B, Choonara I. Use of "off-label" and unlicensed drugs in paediatric intensive care unit. Lancet 1996; 347: 549-550.
5. Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European Countries. BMJ 2000; 320: 79-82.
6. Jong GW, Vulto AG, de Hoog M, Schimmel KJ, Tibboel D, van den Anker JN. Survey of the use of off-label and unlicensed drugs in a Dutch children's hospital. Pediatrics 2001; 108: 1089-1093.
7. Chalumeau M, Treluyer JM, Salanave B, et al. Off label and unlicensed drug use among french office based paediatricians. Arch Dis Child 2000; 83: 502-505.
8. Olubadewo JO, Ikponmwamba A. Profile of prescription medication in a pediatric population. Drug Intell Clin Pharm 1988; 22: 999-1002.
9. Sanz EJ, Bergman U, Dahlstrom M. Paediatric drug prescribing. A comparison of Tenerife (Canary Islands, Spain) and Sweden. Eur J Clin Pharmacol 1989; 37: 65-68.
10. Thrane N, Sorensen HT. A one-year population-based study of drug prescriptions for Danish children. Acta Paediatr 1999; 88: 1131-1136.
11. Straand J, Rokstad K, Heggedal U. Drug prescribing for children in general practice. A report from the More & Romsdal Prescription Study. Acta Paediatr 1998; 87: 218-224.
12. Madsen H, Andersen M, Hallas J. Drug prescribing among Danish children: a population-based study. Eur J Clin Pharmacol 2001; 57: 159-165.
13. Jong GW, Eland IA, Stricker BHC, Anker JN. Information for paediatric use of medicines in a product information compendium. Paediatr Perinat Drug Thera 2001; 4: 148-151.
14. Jong GW, Eland IA, Sturkenboom MC, Van Den Anker JN, Stricker BH. Unlicensed and off label prescription of drugs to children: population based cohort study. BMJ 2002; 324: 1313-1314.
15. Vlug AE, van der Lei J, Mosseveld BM, et al. Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med 1999; 38: 339-344.
16. European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit. Note for Guidance on Clinical Investigation of Medicinal Products in Children. Committee for Proprietary Medicinal Products. London, 1997.
17. Nahata MC. New regulations for pediatric labeling of prescription drugs. Ann Pharmacother 1996; 30: 1032-1033.
18. Physician's Desk Reference. 56th Edn. Montvale, Medical Economics, 2001.
19. The Royal College of Paediatrics and Child Health. Medicines for Children. Hants, UK, B&MBC Books Ltd, Direct Books, 1999.
20. Nahata MC. Lack of pediatric drug formulations. Pediatrics 1999; 104: 607-609.
21. Nahata MC. Pediatric drug formulations: challenges and potential solutions. Ann Pharmacother 1999; 33: 247-249.
22. O'Callaghan C, Barry P. Inhalation devices for young children. Paediatr Perinat Drug Ther 1997; 2: 57-65.
23. Janssens HM, Devadason SG, Hop WC, LeSouef PN, De Jongste JC, Tiddens HA. Variability of aerosol delivery via spacer devices in young asthmatic children in daily life. Eur Respir J 1999; 13: 787-791.
24. McCarthy TP. Use of 'Nebuhaler' and face-mask in young asthmatic children. Lancet 1990; 335: 983-984.
25. Janssens HM, Heijnen EM, de Jong VM, et al. Aerosol delivery from spacers in wheezy infants: a daily life study. Eur Respir J 2000; 16: 850-856.
26. McIntyre J, Conroy S, Avery A, Corns H, Choonara I. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child 2000; 83: 498-501.
27. Schirm E, Tobi H, de Jong-van den Berg LT. Risk factors for unlicensed and off-label drug use in children outside the hospital. Pediatrics 2003; 111: 291-295.
28. Jong GW, van den Anker JN, Choonara I. FDAMA's written request list: medicines for children. Lancet 2001; 357: 398.
29. Pandolfini C, Impicciatore P, Provasi D, Rocchi F, Campi R, Bonati M. Off-label use of drugs in Italy: a prospective, observational and multicentre study. Acta Paediatr 2002; 91: 339-347.
30. Gavrilov V, Lifshitz M, Levy J, Gorodischer R. Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel. Isr Med Assoc J 2000; 2: 595-597.
31. Avenel S, Bomkratz A, Dassieu G, Janaud JC, Danan C. The incidence of prescriptions without marketing product license in a neonatal intensive care unit. Arch Pediatr 2000; 7: 143-147.
32. Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr 1999; 88: 965-968.